Clinical and laboratory profile of patients with tuberculosis/HIV coinfection at a national referral centre: A case series

Eastern Mediterranean Health Journal

Volumn 14, Issue 2, 2008, Pages 283-291

  Tabarsi, P ^a   Mirsaeidi, S M ^a   Amiri, M ^a   Mansouri, S D ^a   Masjedi, M R ^a   Velayati, A A ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; LABORATORY TEST; LUNG TUBERCULOSIS; MALE; MIXED INFECTION; MORTALITY; PRISONER; SEXUAL BEHAVIOR; SPUTUM SMEAR; THORAX RADIOGRAPHY; TOXIC HEPATITIS;

ADULT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEPATITIS C; HEPATITIS, TOXIC; HOSPITALS, URBAN; HUMANS; IRAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRISONERS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK FACTORS; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS, PULMONARY;

EID: 45849145835     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cahn P et al. Tuberculosis and HIV, a partnership against the most vulnerable. Journal of the International Association of Physicians in AIDS Care, 2003, 2(3):106-23.
2. Von Reyn CF, Vuola JM. New vaccines for the prevention of tuberculosis. clinical Infectious diseases, 2002, 35:465-74.
3. Corbett EL et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of internal medicine, 2003, 163:1009-21.
4. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in era of HIV/AIDS. Science, 2003, 301:1535-7.
5. Daley CL et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. New England journal of medicine, 1992, 326:231-5.
6. Selwyn PA et al. A prospective study of the risk of tuberculosis among intravenous drug users with HIV. New England journal of medicine, 1993, 328:1137-44.
7. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. Journal of infectious diseases, 2003, 188(8):1146-55.
8. Davies PDO. The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis. Annals of medicine, 2003, 35(4):235-43.
9. Tuberculosis: strategy and operations, monitoring and evaluation. Geneva, World Health Organization, 2003.
10. Ahya SN, Flood K, Paranjothi S, eds. The Washington manual of medical therapeutics, 30th ed. Philadelphia, Lippincott, Williams and Wilkins, 2001.
11. Mohanty KC, Bendre S. Changing trends in management of HIV and TB. Journal of the Indian Medical Association, 2003, 101(3):186-8.
12. Pathni AK, Chauhan LS. HIV/TB in India: a public health challenge. Journal of the Indian Medical Association, 2003, 101(3):148-9.
13. Morozova I et al. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. International journal of tuberculosis and lung disease, 2003, 7(9):903-6.
14. Batyrov FA et al. Kontingent VICH-infitsirovannykh bol'nykh tuberkulezom v protivotuberkuleznom uchrezhdenii [A category of patients with Tuberculosis concomitant with HIV infection in an anti-TB facility]. Problemy tuberkuleza i boleznei legkikh, 2003, (5):6-9.
15. Garcia Vazquez E, Cedillos RA, Wheeler DA. Clinical and demographic features of HIV infection in El Salvador. Revista panamericana de salud pública, 2003, 13(5):327-31.
16. Leim JM et al. Epidemiology and clinical features of HIV infection/AIDS in Korea. Yonsei medical journal, 2003, 44(3):363-70.
17. Mori T et al. [An observation on tuberculosis associated with HIV infection in Japan.] Kekkaku, 1997, 72(12):649-57 [in Japanese].
18. Dey SK, Pal NK, Chakrabarty MS. Cases of human immunodeficiency virus infection and tuberculosis - early experiences of different aspects. Journal of the Indian Medical Association, 2003, 101(5):291-6.
19. Zamani S et al. Prevalence of and risk factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS, 2005, 19(7):709-16.
20. Senya C et al. Spectrum of opportunistic infections in hospitalized HIV-infected patients in Phnom Penh, Cambodia. International journal of STD & AIDS, 2003, 14(6):411-6.
21. Vajpayee M et al. Spectrum of opportunistic infections land profile of CD4(+) counts among AIDS patients in north India. Infection, 2003; 31(5):336-40.
22. Daicolmo M. Tuberculosis and HIV infection Brazil - update and overview. TB & HIV, 1996, Jun-Aug (11):26.
23. Jorrens JK. HIV and tuberculosis in a rural hospital in Kenya. East African medical journal, 2000, 77(4):185-8.
24. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. New England journal of medicine, 1999, 340(5):367-73.
25. Pasqualotto AC et al. Retrospective study of 668 cultures for Mycobacteria in a reference hospital for AIDS in southern Brazil. Brazilian journal of infectious diseases, 2003, 7(2):126-8.
26. Zumla A et al. Impact of HIV infection on tuberculosis, Postgraduate medical journal, 2000, 70:259-68.
27. Murray J et al. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. American journal of respiratory and critical care medicine, 1999, 159:733-40.
28. Gordin FM et al. The impact of human immunodeficiency virus infection on drug resistant tuberculosis. American journal of respiratory and critical care medicine, 1996, 154:1478-83.
29. Mitike G, Kebede D, Yeneneh H. HIV infection and antituberculosis drug resistance among pulmonary tuberculosis patients in Harar tuberculosis centre, Ethiopia. East African medical journal, 1997, 74:154-7.
30. Perriens JH et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. New England journal of medicine, 1995, 332(12):779-86.
31. Munstiff SS et al. Rifampin-monoresistant tuberculosis in New York city, 1993-1994. Clinical infectious diseases, 1997, 25:1465-7.
32. Lutfey M et al. Independent origin of mono-rifampin-resistant mycobacterium tuberculosis in patients with AIDS. American journal of respiratory and critical care medicine, 1996, 153:837-40.
33. Centers for Disease Control. Treatment for tuberculosis. Morbidity and mortality weekly report, 2003, 52:51-4.
34. Perlman DC et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beim Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clinical infectious diseases, 1997, 25:242-6.
35. Kawooya VK, Kawooya M, Okwera A. Radiographic appearance of pulmonary Tuberculosis in HIV-1 seropositive and seronegative adult patients East African medical journal, 2000, 77(6):303-7.
36. Mayau C, Cadranel J. Tuberculosis in AIDS: past or new problems. Thorax, 1999, 54:567-71.
37. Colebunders R, Lambert ML. Management of co-infection with HIV and TB. British medical journal, 2002, 324:802-3.
38. Centers for Disease Control. The 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and mortality weekly report, 1993, 41(17):1-19.
39. Currie CS et al. Tuberculosis epidemics driven by HIV is prevention better than cure. AIDS, 2003, 17(17):2501-8.
40. Morris L et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. Journal of infectious diseases, 2003, 187(12):1967-71.